| 生物活性 | |||
|---|---|---|---|
| 描述 | AER-271 is a phosphonate prodrug derivative of AER-270, an AQP4 inhibitor used in acute ischaemic stroke studies. AER-271 is converted to AER-270 in vivo by endogenous phosphatases[1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 2.16mL 0.43mL 0.22mL | 10.78mL 2.16mL 1.08mL | 21.57mL 4.31mL 2.16mL | 
| 参考文献 | 
|---|